MASTIVET PARENTERAL
MASTIVET PARENTERAL
Authorised
- Penethamate hydriodide
Product identification
Medicine name:
MASTIVET PARENTERAL
Active substance:
- Penethamate hydriodide
Target species:
-
Cattle (lactating cow)
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Penethamate hydriodide236.30/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Powder and solvent for suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle (lactating cow)
-
Meat and offal4day
-
Milk60hour
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01CE90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Spain
Available in:
-
Spain
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Divasa Farmavic S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Divasa Farmavic S.A.
Responsible authority:
- Spanish Agency For Medicines And Health Products
Authorisation number:
- 2883 ESP
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 9/11/2022
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 9/11/2022
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 9/11/2022
How useful was this page?:
